NMPA Announces Cancellation of Two IVD Product Registrations from Abbott and Agilent
Abbott
Diagnostic and pharmaceutical product manufacturers
Agilent Technologies
Diagnostic Product Provider
// Source of this article: National Medical Products Administration, Compiled by IVD Trends
On January 10, the National Medical Products Administration (NMPA)The Bureau has releasedTwo Announcements on the Cancellation of Registration Certificates for 2 IVD Products Involve Abbott and Agilent Technologies.The specific announcement content is as follows:
01
According to the announcement released by the National Medical Products Administration (NMPA)Regarding "Announcement on the Cancellation of Registration Certificates for Four Medical Devices Including Cone Beam Computed Tomography Equipment for Oral and Maxillofacial Use (No. 2, 2024)" shows,Abbott Diagnostics Medical Co., Ltd. (Japan)’s 1 product: Treponema Pallidum Antibody Detection Kit (Colloidal Selenium Method), Registration Certificate No.: China Medical Device Registration No. 20173402156.
02
According to the announcement released by the National Medical Products Administration regarding "Announcement on the Cancellation of the Medical Device Registration Certificate for the Liquid Chromatography Tandem Mass Spectrometry System (No. 4, 2024)》Shows, according to the provisions of the "Regulations on the Supervision and Administration of Medical Devices," based on the enterprise's application,The medical device registration certificate for the liquid chromatography-tandem mass spectrometry system of Agilent Technologies Singapore (International) Pte. Ltd. is hereby canceled. Registration certificate number: GJXZZJ 20232220080.
※ This article is reprinted, all views belong to the original author.Platform, IVD Alliance remains neutral on all viewpoints in the article and only shares for communication purposes.
IVD Practitioner Professional Handbook
*Advertisement
